Literature DB >> 6313062

Effect of pertussis toxin on the hormonal regulation of cyclic AMP levels in hamster fat cells.

M A Martínez-Olmedo, J A García-Sáinz.   

Abstract

Pertussis toxin was purified approx. 1800-fold from pertussis vaccine. Administration of as little as 1 microgram of toxin/100 g body weight to hamsters markedly decreased the sensitivity of their adipocytes to agents that inhibit adenylate cyclase through receptor-mediated, GTP-dependent mechanisms such as alpha 2-adrenergic amines, prostaglandins, phenylisopropyladenosine and nicotinic acid. On the contrary, the inhibitory effect of 2',5'-dideoxyadenosine on cyclic AMP accumulation was not affected by the toxin. Activation of adenylate cyclase by isoproterenol, ACTH or forskolin was not diminished by the toxin but the maximum cyclic AMP accumulation was consistently increased. Furthermore, the dose-response curves for ACTH and forskolin were clearly shifted to the left in adipocytes from toxin-treated hamsters as compared to control adipocytes. It is concluded that pertussis toxin blocks the transfer of inhibitory information from the receptors to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313062     DOI: 10.1016/0304-4165(83)90166-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Effect of pertussis toxin on normorphine-dependence and on acute inhibitory effects of normorphine and clonidine in guinea-pig isolated ileum.

Authors:  J F Tucker
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

2.  Rat fat-cells have three types of adenosine receptors (Ra, Ri and P). Differential effects of pertussis toxin.

Authors:  J A García-Sáinz; M L Torner
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

Review 3.  In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity.

Authors:  Marieke Esther Hoonakker
Journal:  Toxins (Basel)       Date:  2021-08-12       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.